OriCell Therapeutics Co., Ltd.
3 clinical trials · Sponsor
◉ Watch OriCell Therapeutics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study (NCT06271252) | OriCell Therapeutics Co., Ltd. | 2024-04-03 |
| OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM (NCT06182696) | OriCell Therapeutics Co., Ltd. | 2023-10-26 |
| Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC (NCT05652920) | OriCell Therapeutics Co., Ltd. | 2022-12-15 |
Track OriCell Therapeutics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.